Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy.

Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder associated with increased risk of intrauterine fetal death and prematurity. There is increasing evidence that genetically determined dysfunction in the canalicular ABC transporters bile salt export pump (BSEP, ABCB11) and multidrug resistance protein 3 (MDR3, ABCB4) might be risk factors for ICP development. This study aimed to (i). describe the extent of genetic variability in BSEP and MDR3 in ICP and (ii). identify new disease-causing mutations. Twenty-one women with ICP and 40 women with uneventful pregnancies were recruited between April 2001 and April 2003. Sequencing of BSEP and MDR3 spanned 8-10 kb per gene and comprised the promoter region and 100-350 bp of the flanking intronic region around each exon. DNA sequencing of polymerase chain reaction fragments was performed on an ABI3700 capillary sequencer. MDR3 promoter activity of promoter constructs carrying different ICP-specific mutations was studied using reporter assays. A total of 37 and 51 variant sites were detected in BSEP and MDR3, respectively. Three non-synonymous sites in codons for evolutionarily conserved amino acids were specific for the ICP collective (BSEP, N591S; MDR3, S320F and G762E). Furthermore, four ICP-specific splicing mutations were detected in MDR3 [intron 21, G(+1)A; intron 25, G(+5)C and C(-3)G; and intron 26, T(+2)A]. Activity of the mutated MDR3 promoter was similar to that observed for the wild-type promoter. Our data further support an involvement of MDR3 genetic variation in the pathogenesis of ICP, whereas analysis of BSEP sequence variation indicates that this gene is probably less important for the development of pregnancy-associated cholestasis.

[1]  E. Elias,et al.  Obstetric cholestasis with elevated gamma glutamyl transpeptidase: Incidence, presentation and treatment , 2003, Journal of gastroenterology and hepatology.

[2]  K. Aittomäki,et al.  Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy , 2003, Gut.

[3]  Conrad C. Huang,et al.  Natural variation in human membrane transporter genes reveals evolutionary and functional constraints , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Prieto,et al.  A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. , 2003, Gastroenterology.

[5]  C. Andres,et al.  A second heterozygous MDR3 nonsense mutation associated with intrahepatic cholestasis of pregnancy , 2003, Journal of medical genetics.

[6]  A. Mannermaa,et al.  Multidrug resistance 3 gene mutation 1712delT and estrogen receptor alpha gene polymorphisms in Finnish women with obstetric cholestasis. , 2002, European journal of obstetrics, gynecology, and reproductive biology.

[7]  A. Shennan,et al.  Obstetric cholestasis, outcome with active management: a series of 70 cases , 2002, BJOG : an international journal of obstetrics and gynaecology.

[8]  P. Bosma,et al.  The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. , 2001, Gastroenterology.

[9]  D. Meijer,et al.  Mrp2 is essential for estradiol‐17β(β‐D ‐glucuronide)–induced cholestasis in rats , 2000 .

[10]  M. McCarthy,et al.  Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. , 2000, Human molecular genetics.

[11]  P. Meier,et al.  Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. , 2000, Gastroenterology.

[12]  M. Hadchouel,et al.  Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy , 1999, The Lancet.

[13]  Richard J. Thompson,et al.  A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis , 1998, Nature Genetics.

[14]  J. Ribalta,et al.  Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy. , 1997, Journal of hepatology.

[15]  Y. Bacq,et al.  Intrahepatic cholestasis of pregnancy: A French prospective study , 1997, Hepatology.

[16]  F. Simon,et al.  Intrahepatic Cholestasis of Pregnancy: An Estrogen-Related Disease , 1993, Seminars in liver disease.

[17]  M. Arrese,et al.  Intrahepatic cholestasis of pregnancy in twin pregnancies. , 1989, Journal of hepatology.

[18]  A. M. van der Bliek,et al.  Sequence of mdr3 cDNA encoding a human P-glycoprotein. , 1988, Gene.

[19]  K. Byth,et al.  Serum bile acid concentrations during pregnancy and their relationship to obstetric cholestasis. , 1986, Gastroenterology.

[20]  P. Ylöstalo,et al.  CHANGES IN SERUM BILE ACID CONCENTRATIONS DURING NORMAL PREGNANCY, IN PATIENTS WITH INTRAHEPATIC CHOLESTASIS OF PREGNANCY AND IN PREGNANT WOMEN WITH ITCHING , 1981, British journal of obstetrics and gynaecology.

[21]  M. Hiltunen,et al.  Association of single nucleotide polymorphisms of the bile salt export pump gene with intrahepatic cholestasis of pregnancy. , 2003, Scandinavian journal of gastroenterology.

[22]  P. Meier,et al.  Bile salt transporters. , 2002, Annual review of physiology.